Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PBH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsPrestige Consumer Healthcare issues $400M of 6.25% senior notes due 2034
Filed July 15, 2026 · Period ending July 15, 2026 · ~1 min read
Key Changes
-
high
Prestige Brands (wholly owned subsidiary) issued $400M aggregate principal of 6.25% senior notes maturing July 15, 2034, with semi-annual interest payments beginning January 2027. Notes are guaranteed by parent and certain domestic subsidiaries.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Indenture restricts additional debt, dividends, asset sales, liens, mergers, and affiliate transactions, limiting financial flexibility but subject to standard exceptions for high-yield debt.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Company may redeem notes after July 2029 at scheduled prices, or earlier at par plus make-whole premium. Change of control triggers repurchase offer at 101% of principal.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
medium
Standard default triggers include missed payments, covenant breaches, cross-defaults, material judgments, guarantee failures, and bankruptcy events, with grace and cure periods in certain cases.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
low
Notes sold privately to qualified institutional buyers under Rule 144A and offshore investors under Regulation S, avoiding SEC registration.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
Summary
Prestige Consumer Healthcare raised $400 million through a private placement of senior unsecured notes by its wholly owned subsidiary Prestige Brands. The 6.25% coupon and 2034 maturity add fixed-rate debt to the capital structure, with semi-annual interest payments starting in early 2027. The notes carry parent and subsidiary guarantees, making them senior unsecured obligations of the consolidated group.
The indenture imposes typical high-yield covenants restricting additional borrowing, dividends, asset sales, and related-party transactions, which will constrain financial flexibility going forward. Redemption optionality after mid-2029 and change-of-control protections are standard for this debt class.
The filing does not disclose use of proceeds, so investors should watch for management commentary on deployment—whether for refinancing existing debt, acquisitions, or general corporate purposes. The 6.25% rate reflects current market conditions for the company's credit profile; holders should monitor leverage trends and covenant headroom as the debt seasons.
Section-by-Section Diff
Event · Item 2.03 — Creation of a Direct Financial Obligation
Item 2.03 also reports this as a direct financial obligation (body incorporates the primary Item by reference).
Added in current filing · verify on EDGAR →
Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01 is incorporated by reference into this Item 2.03.
The company also filed this under Item 2.03, which means it is reporting the arrangement as a direct financial obligation. The Item 2.03 text refers back to the Item 1.01 entry for the terms rather than restating them.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jul 16, 2026 · How we verify